Safety and Efficacy of Topical Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Pilot Study
Purpose. Evaluate safety and efficacy of topical lotilaner ophthalmic solution, 0.25% for the treatment of Demodex blepharitis. Patients and Methods. 15 patients with Demodex blepharitis, defined as >10 collarettes on the upper lid, lid margin erythema, and Demodex density of ≥1.5 mites/lash on m...
Saved in:
Main Authors: | Roberto Gonzalez-Salinas, Elizabeth Yeu, Mark Holdbrook, Stephanie N. Baba, Juan Carlos Ceballos, Martha Massaro-Corredor, Claudia Corredor-Ortega, Nallely Ramos-Betancourt, Hugo Quiroz-Mercado |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2021/3862684 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Global Trends in Studies on the Presence of Demodex spp in Patients Diagnosed with Blepharitis
by: Rahmi Yildiz, et al.
Published: (2024-08-01) -
A Comparative Study of 0.25% Levobupivacaine, 0.25% Ropivacaine, and 0.25% Bupivacaine in Paediatric Single Shot Caudal Block
by: Jagdeep Sharma, et al.
Published: (2018-01-01) -
Demodex and the eye – A review
by: Sumana Chatterjee, et al.
Published: (2025-01-01) -
Design and fabrication of (Hf0.25Zr0.25Ta0.25Nb0.25)C–SiC ceramics with improved microwave absorbing properties via PDC route
by: Bin Du, et al.
Published: (2025-01-01) -
Topical Ophthalmic Cyclosporine in the Treatment of Toxic Epidermal Necrolysis
by: Zafer Onaran, et al.
Published: (2011-01-01)